Search
Proxalutamide
go.drugbank.com/drugs/DB16065InvestigationalProxalutamide is under investigation in clinical trial NCT03899467 (The Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer).
BHV-1310
go.drugbank.com/drugs/DB22674ExperimentalBHV-1310 is a IgG1,2,4 selective degrader being investigated for the treatment of Grave's disease.
BL-1020
go.drugbank.com/drugs/DB05687InvestigationalBL-1020 is a first in class novel compound for the treatment of schizophrenia. It is being developed by BioLineRx (BioLine).
Cryptenamine
go.drugbank.com/drugs/DB00785ApprovedIt has been used in the treatment of hypertension but has largely been replaced by drugs with fewer adverse effects.
Naproxcinod
go.drugbank.com/drugs/DB06682InvestigationalSynonyms: Naproxen-N-butyl nitrateCategories: Antiinflammatory and Antirheumatic Products, Non-SteroidsOlpadronic acid
go.drugbank.com/drugs/DB20303InvestigationalOlpadronic acid is a small molecule drug. Olpadronic acid has a monoisotopic molecular weight of 263.03 Da.
Categories: Bone Density Conservation AgentsEpinastine
go.drugbank.com/drugs/DB00751ApprovedIt has a multi-action effect that inhibits the allergic response in 3 ways: 1. stabilizes mast cells by preventing mast cell degranulation to control the allergic response, 2. prevents histamine binding
PRTX-100
go.drugbank.com/drugs/DB05947InvestigationalPRTX-100 is a highly-purified form of Staphylococcal Protein A that binds directly to monocytes and a subset of B-cells that are involved in the development and progression of various autoimmune diseases
Anecortave acetate
go.drugbank.com/drugs/DB05288InvestigationalAnecortave acetate (Retaane) is an analog of cortisol acetate; among the modifications to the steroid are the removal of the 11ß hydroxyl OH group and an addition of a 21-acetate group.